Literature DB >> 13680079

Elevated startle during withdrawal from acute morphine: a model of opiate withdrawal and anxiety.

Andrew C Harris1, Jonathan C Gewirtz.   

Abstract

RATIONALE: An elevated startle response has been observed in humans and animals during withdrawal from multiple substances of abuse, a phenomenon thought to reflect the anxiogenic effects of withdrawal. Although anxiety is a common symptom of opiate withdrawal, few studies have examined the effects of morphine withdrawal on acoustic startle.
OBJECTIVE: To develop a procedure for assessing opiate dependence through measurement of the startle reflex in rats.
METHODS: The effects of opiate withdrawal on startle were evaluated using both spontaneous and naloxone-precipitated withdrawal from an acute dose of morphine. The ability of the treatment drugs clonidine and chlordiazepoxide to block withdrawal-induced increases in startle was also tested.
RESULTS: Spontaneous withdrawal from an injection of morphine sulfate produced a significant increase in acoustic startle 2 h (3.2 mg/kg) or 4 h (10 mg/kg) after drug administration. Morphine withdrawal (10 mg/kg morphine sulfate) precipitated by the opiate antagonist naloxone (2.5 mg/kg) also produced a significant increase in startle magnitude. This elevation of startle was blocked by both clonidine (35 microg/kg) and chlordiazepoxide (10 mg/kg).
CONCLUSIONS: These data demonstrate that both spontaneous and precipitated withdrawal from an acutely administered opiate produce anxiety-like effects on acoustic startle. This paradigm may be useful in the study of anxiety and the early mechanisms of drug dependence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13680079     DOI: 10.1007/s00213-003-1573-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  44 in total

1.  Methadone patients exhibit increased startle and cortisol response after intravenous yohimbine.

Authors:  S M Stine; C G Grillon; C A Morgan; T R Kosten; D S Charney; J H Krystal
Journal:  Psychopharmacology (Berl)       Date:  2001-03       Impact factor: 4.530

2.  Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats.

Authors:  D L Walker; M Davis
Journal:  Biol Psychiatry       Date:  1997-09-15       Impact factor: 13.382

3.  Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats.

Authors:  J U Adams; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1990-05       Impact factor: 4.030

4.  Evidence of possible opiate dependence during the behavioral depressant action of a single dose of morphine.

Authors:  D R Meyer; S B Sparber
Journal:  Life Sci       Date:  1977-10-15       Impact factor: 5.037

5.  Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval II.

Authors:  K C Kirby; M L Stitzer; S J Heishman
Journal:  J Pharmacol Exp Ther       Date:  1990-11       Impact factor: 4.030

6.  Fear-potentiated startle in two strains of inbred mice.

Authors:  W A Falls; S Carlson; J G Turner; J F Willott
Journal:  Behav Neurosci       Date:  1997-08       Impact factor: 1.912

7.  Pharmacokinetics and pharmacodynamics of subcutaneous morphine pellets in the rat.

Authors:  B C Yoburn; J Chen; T Huang; C E Inturrisi
Journal:  J Pharmacol Exp Ther       Date:  1985-11       Impact factor: 4.030

8.  A primary acoustic startle pathway: obligatory role of cochlear root neurons and the nucleus reticularis pontis caudalis.

Authors:  Y Lee; D E López; E G Meloni; M Davis
Journal:  J Neurosci       Date:  1996-06-01       Impact factor: 6.167

9.  Rat brain monoamine oxidase A and B inhibitory (tribulin) activity during drug withdrawal anxiety.

Authors:  S K Bhattacharya; A Chakrabarti; M Sandler; V Glover
Journal:  Neurosci Lett       Date:  1995-10-20       Impact factor: 3.046

10.  Yohimbine exacerbates and clonidine attenuates acute morphine withdrawal in rats.

Authors:  L P Dwoskin; B S Neal; S B Sparber
Journal:  Eur J Pharmacol       Date:  1983-06-03       Impact factor: 4.432

View more
  34 in total

1.  Increased dopamine receptor activity in the nucleus accumbens shell ameliorates anxiety during drug withdrawal.

Authors:  Anna K Radke; Jonathan C Gewirtz
Journal:  Neuropsychopharmacology       Date:  2012-06-13       Impact factor: 7.853

2.  Episodic withdrawal promotes psychomotor sensitization to morphine.

Authors:  Patrick E Rothwell; Jonathan C Gewirtz; Mark J Thomas
Journal:  Neuropsychopharmacology       Date:  2010-09-01       Impact factor: 7.853

3.  Protracted manifestations of acute dependence after a single morphine exposure.

Authors:  Patrick E Rothwell; Mark J Thomas; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

4.  Chronic CRF1 receptor blockade reduces heroin intake escalation and dependence-induced hyperalgesia.

Authors:  Paula E Park; Joel E Schlosburg; Leandro F Vendruscolo; Gery Schulteis; Scott Edwards; George F Koob
Journal:  Addict Biol       Date:  2013-12-13       Impact factor: 4.280

Review 5.  Acute opioid dependence: characterizing the early adaptations underlying drug withdrawal.

Authors:  Andrew C Harris; Jonathan C Gewirtz
Journal:  Psychopharmacology (Berl)       Date:  2005-02-05       Impact factor: 4.530

6.  Effects of age, but not sex, on elevated startle during withdrawal from acute morphine in adolescent and adult rats.

Authors:  Anna K Radke; Jonathan C Gewirtz; Marilyn E Carroll
Journal:  Behav Pharmacol       Date:  2015-08       Impact factor: 2.293

7.  Effects of repeated morphine on ultrasonic vocalizations in adult rats: increased 50-kHz call rate and altered subtype profile.

Authors:  Laura M Best; Leah L Zhao; Tina Scardochio; Paul B S Clarke
Journal:  Psychopharmacology (Berl)       Date:  2016-10-11       Impact factor: 4.530

8.  Association between initial morphine intake and body weight change, acoustic startle reflex and drug seeking in rats.

Authors:  Thien Le; Mercedes Xia; Min Jia; Nathan Sarkar; Jerry Chen; He Li; Gary H Wynn; Robert J Ursano; Kwang H Choi
Journal:  Psychopharmacology (Berl)       Date:  2014-05-13       Impact factor: 4.530

9.  Reduced emotional signs of opiate withdrawal in rats selectively bred for low (LoS) versus high (HiS) saccharin intake.

Authors:  Anna K Radke; Nathan A Holtz; Jonathan C Gewirtz; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2012-12-20       Impact factor: 4.530

10.  Corticotropin-releasing factor (CRF) and α 2 adrenergic receptors mediate heroin withdrawal-potentiated startle in rats.

Authors:  Paula E Park; Leandro F Vendruscolo; Joel E Schlosburg; Scott Edwards; Gery Schulteis; George F Koob
Journal:  Int J Neuropsychopharmacol       Date:  2013-04-16       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.